Navigation Links
ITRAC on track and bridging gap between academic research and applied discovery
Date:1/25/2008

INDIANAPOLIS -- In a novel manner which gives new meaning to the word transformative, researchers from the Indiana University Melvin and Bren Simon Cancer Center are integrating some of the best practices of industry into the strengths of the academic research process to propel the development of innovative cancer treatments from the bench to the bedside.

The IU Simon Cancer Center has initiated the Translational Research Acceleration Collaboration (ITRAC) and is providing rapid response funding and expertise to speed early discoveries to improve patient care, solve perplexing treatment problems, and lead the way to future therapies.

Traditionally, external academic grant funding applications take nine to 12 months from time of submission to funding, if approved. With ITRAC, researchers can receive incremental funding in a fraction of that time.

"ITRAC also helps investigators form research teams and break down silos that are naturally found in any research environment, said Mark Kelley, Ph.D., associate director for basic science research at the IU Simon Cancer Center. "The ITRAC process requires that research teams, including basic and clinical scientists, work together to speed the velocity of the science from the bench to the clinic as well as from the clinic back to the bench. With science becoming ever more complex, the formation of multi-disciplinary teams is the most effective and correct way to undertake complex problems in cancer prevention, detection, treatment and delivery.

This initiative also helps investigators forge new collaborations, share costly resources such as reagents, and develop interactions internally and externally. To date, ITRAC has supported collaborators from the Purdue Cancer Center, the University of Notre Dames Walther Cancer Research Center and the IU Simon Cancer Center.

According to Dr. Kelley, the ITRAC process requires greater accountability by researchers of how funds are used and careful scrutiny of the outcomes. Only research with the greatest patient impact potential is supported.

David Johnson, president and CEO of BioCrossroads, the states initiative to develop the life sciences, said hes not aware of any other university using ITRACs approach to translate discovery into action.

Its revolutionary, Johnson said. Although its in an academic environment, ITRAC tries to bridge the gap between the traditional the pure discovery domain of academic research and the very applied discovery domain of corporate research and development. Its an approach that says were going to borrow some of the project management processes that organize corporate research and focus more specifically on outcomes.

Leaders at the IU Simon Cancer Center approached BioCrossroads for insights into project management practices used in the corporate world.

In addition to grant money, ITRAC helps researchers map out their projects, and it provides expertise to scientists who have made significant discoveries in their labs but arent sure what steps are necessary to turn those discoveries into products that will improve patient care. This decreases the amount of time the scientists have to spend running around trying to find out how to accomplish the next step in their projects.

The program complements a growing emphasis by the National Institutes of Health on accelerating the development and testing processes that basic science laboratory discoveries go through to become new patient treatments. One of the major goals of National Cancer Institute designated centers like the IU Simon Cancer Center is to increase translational initiatives.

IU Simon Cancer Center committees review research projects and identify those with the most potential for clinical applications as well as commercial potential potential that the individual scientists may not even realize is there.

Since its establishment in November 2006, ITRAC has mapped 73 projects, established and/or recommended 50 project collaborations, and identified numerous intellectual property needs.

After little more than a year, an exciting benefit we are seeing is the identification of intellectual property, which, we hope, will continue to grow and dovetail with the growing emphasis in the states life sciences initiative and lead to more biotech startups and licensing opportunities and decrease the brain drain from the state, Kelley said. Whatever it takes to help speed research findings to help cancer patients is what this initiative is all about."


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University
Source:Eurekalert

Related medicine news :

1. Bayer HealthCare Cleared to Acquire Citracal(R)
2. TNF-alpha antagonist stops inflammation-induced colon cancer in its tracks
3. Mapping tool allows emergency management personnel to visually track resources
4. KLAS Ranks TeleTracking Bed Management Suite No. 1
5. Online Resource Keeps Restaurant Diners on Track After New Years Hype Subsides
6. Breaking Studies at AARC Congress Show Masimo SET and Masimo Rainbow SET to be Accurate, Effective and Uniquely Beneficial in Detecting and Tracking Disease States
7. Tracking Drug Levels Helps Pregnant Women With Epilepsy
8. Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 With Trial Fully Recruited and European and US Submission On Track for First Half of 2008
9. Design of patient tracking tools may have unintended consequences
10. Scientists Find Way to Track Stem Cells in Brain
11. Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... ... , ... The San Juan Capistrano summer camp team at the Boys and Girls ... summer camps to provide physical activities for all campers. To read the report, click ... With an increase in specialty camps that focus on what the report terms as “sitting ...
(Date:4/21/2017)... ... ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , has found the ... located on the forehead usually attributed to a facial fracture. Their appearance is not ... has discovered an approach that is minimally invasive. He is an expert at this ...
(Date:4/21/2017)... City, Colo. (PRWEB) , ... April 21, 2017 , ... ... of the Flex House, the next project in the company’s esteemed VISION House demonstration ... help homeowners use exactly the amount of resources they need to live affordably and ...
(Date:4/21/2017)... VA (PRWEB) , ... April 21, 2017 , ... ... its first weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from ... evidence in treating and preventing substance use disorders. , The mission of ...
(Date:4/21/2017)... Annapolis, MD (PRWEB) , ... ... ... leading accreditation organization promoting quality-based imaging practices, is seeking candidates to serve ... activities for diagnostic imaging. , “RadSite’s ultimate mission is improving image ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, ... today unveiled a new store design to enhance ... of healthier food, health-focused products and expanded beauty ... to help customers discover new offerings. Together with ... next evolution of the customer experience at CVS ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
Breaking Medicine Technology: